Catheter Precision, Inc. (NYSE/American:VTAK), a company dedicated in the development and marketing of technologically advanced products for the cardiac electrophysiology market, today announced ...
KP.3.1.1 and LB.1 in vitro neutralization potency values now reflected in the PEMGARDA Fact Sheet for Healthcare Providers are in-line with prior ...
A man has been charged with 'wounding' after a disorder broke out in Coventry. It happened on Proffitt Avenue. Police were called to reports of a disorder on Proffitt Avenue at around 12pm on ...
A kind-hearted Coventry couple whose young son was diagnosed with cancer have raised more than £17,000 for the UHCW NHS Trust. Corinne Sullivan and Lewis Stothard have worked tirelessly to raise ...
Sports Mole previews Tuesday's Championship clash between Coventry City and Blackburn Rovers, including predictions, team news and possible lineups. Underachieving Coventry City host overachieving ...
University Hospitals Coventry and Warwickshire NHS Trust said about half of those patients were later readmitted. It said a research study funded by funded by the National Institute for Health and ...
Follow live coverage as Leeds United face Coventry City in the Championship today. An increasingly competitive second tier in English football remains an intense and exciting competition ...
Leeds United closed the gap to second place to just two points in the Championship, following a 3-0 victory over out-of-form Coventry City at Elland Road. (More Football News) Wilfried Gnonto got ...
The U.S. Food and Drug Administration (FDA) on Thursday approved Cobenfy (xanomeline and trospium chloride), developed by Bristol-Myers Squibb (NYSE:BMY), as a novel treatment for adults with the ...
The U.S. Food and Drug Administration (FDA) on Thursday approved Bristol Myers Squibb’s (BMY) highly anticipated schizophrenia drug, Cobenfy. It’s the first novel treatment for the ...
It is a severe, chronic mental illness that is often damaging to a person's quality of life," said Dr. Tiffany Farchione, director of psychiatry in the Office of Neuroscience in the FDA's Center ...
The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia, the FDA announced Thursday. The drug, generically called Cobenfy, is the first oral medication to treat ...